These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 20596636)
21. NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma. Wang H; Luo Q; Feng X; Zhang R; Li J; Chen F BMC Cancer; 2018 May; 18(1):500. PubMed ID: 29716544 [TBL] [Abstract][Full Text] [Related]
22. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780 [TBL] [Abstract][Full Text] [Related]
23. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells. Dai J; Wei W Arch Oral Biol; 2017 Nov; 83():40-46. PubMed ID: 28697409 [TBL] [Abstract][Full Text] [Related]
24. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma. Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023 [TBL] [Abstract][Full Text] [Related]
25. Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma. Ko SY; Lin SC; Wong YK; Liu CJ; Chang KW; Liu TY Cancer Lett; 2007 Jan; 245(1-2):33-43. PubMed ID: 16309826 [TBL] [Abstract][Full Text] [Related]
26. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Kang MK; Kim RH; Kim SJ; Yip FK; Shin KH; Dimri GP; Christensen R; Han T; Park NH Br J Cancer; 2007 Jan; 96(1):126-33. PubMed ID: 17179983 [TBL] [Abstract][Full Text] [Related]
27. [Expression of cytokeratin 17 in oral squamous cell carcinoma]. Wei K; Zhang L; Yang X; Han W; Zhong L; Ye D; Zhiyuan Z Hua Xi Kou Qiang Yi Xue Za Zhi; 2011 Aug; 29(4):404-8. PubMed ID: 21932664 [TBL] [Abstract][Full Text] [Related]
28. S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway. Li A; Shi D; Xu B; Wang J; Tang YL; Xiao W; Shen G; Deng W; Zhao C Mol Carcinog; 2017 Mar; 56(3):972-984. PubMed ID: 27596819 [TBL] [Abstract][Full Text] [Related]
29. Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis. Sartini D; Lo Muzio L; Morganti S; Pozzi V; Di Ruscio G; Rocchetti R; Rubini C; Santarelli A; Emanuelli M Oral Dis; 2015 May; 21(4):462-9. PubMed ID: 25439053 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of PAX5 in oral carcinogenesis. Norhany S; Kouzu Y; Uzawa K; Hayama M; Higo M; Koike H; Kasamatu A; Tanzawa H Oncol Rep; 2006 Nov; 16(5):1003-8. PubMed ID: 17016584 [TBL] [Abstract][Full Text] [Related]
31. Regulation of Oral Squamous Cell Carcinoma Proliferation Through Crosstalk Between SMAD7 and CYLD. Ge WL; Xu JF; Hu J Cell Physiol Biochem; 2016; 38(3):1209-17. PubMed ID: 26982322 [TBL] [Abstract][Full Text] [Related]
32. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression. Vigneswaran N; Baucum DC; Wu J; Lou Y; Bouquot J; Muller S; Zacharias W BMC Cancer; 2007 Jun; 7():108. PubMed ID: 17592646 [TBL] [Abstract][Full Text] [Related]
33. Ebp1 activates podoplanin expression and contributes to oral tumorigenesis. Mei Y; Zhang P; Zuo H; Clark D; Xia R; Li J; Liu Z; Mao L Oncogene; 2014 Jul; 33(29):3839-50. PubMed ID: 23975429 [TBL] [Abstract][Full Text] [Related]
34. MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9. Wang K; Jin J; Ma T; Zhai H J Cell Mol Med; 2017 Dec; 21(12):3730-3740. PubMed ID: 28780773 [TBL] [Abstract][Full Text] [Related]
35. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer. Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310 [TBL] [Abstract][Full Text] [Related]
36. Epigenetic control of the S100A6 (calcyclin) gene expression. Leśniak W; Słomnicki ŁP; Kuźnicki J J Invest Dermatol; 2007 Oct; 127(10):2307-14. PubMed ID: 17495951 [TBL] [Abstract][Full Text] [Related]
37. Comparative proteomic analysis of oral squamous cell carcinoma and adjacent non-tumour tissue from Thailand. Chanthammachat P; Promwikorn W; Pruegsanusak K; Roytrakul S; Srisomsap C; Chokchaichamnankit D; Svasti J; Boonyaphiphat P; K S; Thongsuksai P Arch Oral Biol; 2013 Nov; 58(11):1677-85. PubMed ID: 24112734 [TBL] [Abstract][Full Text] [Related]
38. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Ohuchida K; Mizumoto K; Ishikawa N; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M Clin Cancer Res; 2005 Nov; 11(21):7785-93. PubMed ID: 16278400 [TBL] [Abstract][Full Text] [Related]
39. Expression of growth differentiation factor 15 is positively correlated with histopathological malignant grade and in vitro cell proliferation in oral squamous cell carcinoma. Zhang L; Yang X; Pan HY; Zhou XJ; Li J; Chen WT; Zhong LP; Zhang ZY Oral Oncol; 2009 Jul; 45(7):627-32. PubMed ID: 18805046 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma. Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]